Quarter
Charts

IRADIMED CORPORATION — Earnings

Most recent reported period: FY2026 (Q1) (filed for period ending 2026-03-31) · sourced from SEC EDGAR

← Calendar (this week)
Next earnings (estimated): Tue, June 30, 2026 — ~58 days away. Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
Recent · last 8 quartersFuture · next 8 quarters
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2026-03-31$22M↑+12.6%$6M↑+24.1%32.9%
2025-12-31$23M↑+17.0%$6M↑+25.2%31.3%
2025-09-30$21M↑+15.7%$6M↑+10.4%32.2%
2025-06-30$20M↑+13.8%$6M↑+17.8%33.3%
2025-03-31$20M↑+10.9%$5M↑+13.3%27.8%
2024-12-31$19M↑+11.1%$5M↑+13.4%29.9%
2024-09-30$18M↑+11.0%$5M↓-0.3%31.6%
2024-06-30$18M↑+11.1%$5M↑+17.3%31.4%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2026 (Q1)

Revenue
$22M
↑+12.6% +$2M YoY
Net Income
$6M
↑+24.1% +$1M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 52 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+0.4pts
76.5%
Operating Margin↑+5.1pts
32.9%
Net Margin↑+2.4pts
26.5%

Go deeper

IRMD Sankey — flow of dollars

See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.

Open Sankey

IRMD Key Metrics — EPS, ROE, ROIC

10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.

Open Key Metrics